Subcutaneous Drug Delivery Market: By Product (Pen Injectors, Prefilled Syringes, Wearable Injectors), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and online Pharmacies), and Region (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)  

Purchase Option

$ 4400
$ 6600
$ 8900

Subcutaneous drug delivery market size was valued at USD 20.6 billion in the year 2022 and is anticipated to grow at USD 45.53 billion till 2029, witnessing a CAGR of around 12% from 2023 to 2029. The Subcutaneous drug delivery system is a workable alternative for intravenous administration system. Fast development of biologics gives rise to the use of subcutaneous drug delivery. The use of this system is mainly preferred due to its benefits such as improves quality of life, allows self-medication and consequently lessens healthcare costs. A few major factors contribute towards the growth of the global subcutaneous drug delivery market are expediency and protection provided by this system for medical experts and patients. Several health experts are suffered from infectious illnesses in 2014 as a consequent of needle stick wounds according to World Health Organization and this unique system works effectively to lessen the prevalence of needle stick damages. Subcutaneous drugs are given in the skin’s layer named cutis, which contains the dermis and epidermis. There are several pharmaceutical products developed and sold to treat different illnesses which are given through subcutaneous routes. The report gives a comprehensive outlook on subcutaneous drug delivery market across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Bn) on the basis of product, distribution Channel and region. This report studies global subcutaneous drug delivery market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in global subcutaneous drug delivery.

Subcutaneous Drug Delivery Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

12%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Subcutaneous Drug Delivery Market Dynamics

There are many significant factors that contribute towards the growth of the subcutaneous drug deliver market and implementation of inorganic growth strategies by industry players is one of that. Key players focus more on inorganic strategies to give that important place to their products in the market. Growing focus on protecting the needle stick damage is given, which lead towards the growth of the market. Needle stick damages with lacing systems and injection needled are a major anxiety among diabetes patients. Growing alertness about safety and concern about needle stick damages are main factors booming the subcutaneous drug deliver market growth. The unavailability of the approved products because of rising number of product recalls by different developers is a market restricting factor.

Subcutaneous Drug Delivery Market Segmentation

By Product
  • Pen injectors
  • Auto-injectors
  • Prefilled syringes
  • Wearable injectors
  • Needle-free Injectors
By Distribution Channel
  • Online pharmacies
  • Hospital pharmacies
  • Retail pharmacies
By Geography
  • North America
  • Europe
  • Asia Pacifi
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Subcutaneous Drug Delivery Market size was valued at USD 20.6 billion in the year 2022 and is anticipated to grow at USD 45.53 billion till 2029.

Subcutaneous Drug Delivery Market is poised to grow at a significant 12% from 2023 to 2029.

Asia Pacific is the fastest-growing for Subcutaneous Drug Delivery Market

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup's details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market
1.Executive Summary
2.Global Subcutaneous Drug Delivery Market Introduction 
2.1.Global Subcutaneous Drug Delivery Market  - Taxonomy
2.2.Global Subcutaneous Drug Delivery Market  - Definitions
2.2.1.Product
2.2.2.Distribution Channel
2.2.3.Region
3.Global Subcutaneous Drug Delivery Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Subcutaneous Drug Delivery Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Subcutaneous Drug Delivery Market  By Product, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Pen injectors
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Auto-injectors
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Prefilled syringes
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Wearable injectors
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Needle-free Injectors
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Subcutaneous Drug Delivery Market  By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Online pharmacies
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Hospital pharmacies
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Retail pharmacies
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Subcutaneous Drug Delivery Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Subcutaneous Drug Delivery Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Product Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Pen injectors
8.1.2.Auto-injectors
8.1.3.Prefilled syringes
8.1.4.Wearable injectors
8.1.5.Needle-free Injectors
8.2.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Online pharmacies
8.2.2.Hospital pharmacies
8.2.3.Retail pharmacies
8.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Subcutaneous Drug Delivery Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Pen injectors
9.1.2.Auto-injectors
9.1.3.Prefilled syringes
9.1.4.Wearable injectors
9.1.5.Needle-free Injectors
9.2.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Online pharmacies
9.2.2.Hospital pharmacies
9.2.3.Retail pharmacies
9.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
10.Asia Pacific (APAC) Subcutaneous Drug Delivery Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Pen injectors
10.1.2.Auto-injectors
10.1.3.Prefilled syringes
10.1.4.Wearable injectors
10.1.5.Needle-free Injectors
10.2.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Online pharmacies
10.2.2.Hospital pharmacies
10.2.3.Retail pharmacies
10.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Subcutaneous Drug Delivery Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Pen injectors
11.1.2.Auto-injectors
11.1.3.Prefilled syringes
11.1.4.Wearable injectors
11.1.5.Needle-free Injectors
11.2.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Online pharmacies
11.2.2.Hospital pharmacies
11.2.3.Retail pharmacies
11.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Subcutaneous Drug Delivery Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Pen injectors
12.1.2.Auto-injectors
12.1.3.Prefilled syringes
12.1.4.Wearable injectors
12.1.5.Needle-free Injectors
12.2.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Online pharmacies
12.2.2.Hospital pharmacies
12.2.3.Retail pharmacies
12.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Gerresheimer AG
13.2.2.Insulet Corporation
13.2.3.Ypsomed AG
13.2.4.Unilife Corporation
13.2.5.West Pharmaceutical Services, Inc.
13.2.6.Novo Nordisk
13.2.7.Medtronic Plc
13.2.8.Elcam Medical Group
13.2.9.Becton, Dickinson and Company
13.2.10.PharmaJet
13.2.11.Inolife Sciences
14. Research Methodology 
15. Appendix and Abbreviations 
  • Gerresheimer AG
  • Insulet Corporation
  • Ypsomed AG
  • Unilife Corporation
  • West Pharmaceutical Services, Inc.
  • Novo Nordisk
  • Medtronic Plc
  • Elcam Medical Group
  • Becton, Dickinson and Company
  • PharmaJet
  • Inolife Sciences

Adjacent Markets